<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2022-16-10-110-114</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-6937</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДРУГИЕ ПРОБЛЕМЫ ЭНДОКРИНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OTHER PROBLEMS OF ENDOCRINOLOGY</subject></subj-group></article-categories><title-group><article-title>Антенатальное применение глюкокортикостероидов: механизмы программирования здоровья детей</article-title><trans-title-group xml:lang="en"><trans-title>Antenatal glucocorticosteroids treatment: mechanisms of child healths programming</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8632-3075</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шайтарова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shaitarova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шайтарова Анна Владимировна, кандидат медицинских наук, доцент кафедры педиатрии Института непрерывного профессионального развития</p><p>625023, Тюмень, ул. Одесская, д. 54</p></bio><bio xml:lang="en"><p>Anna V. Shaitarova, Cand. Sci. (Med.), Associate Professor of the Department of Pediatrics at the Institute of Continuous Professional Development</p><p>54, Odesskaya St., Tyumen, 625023</p></bio><email xlink:type="simple">annashaytarova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9253-8075</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суплотова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Suplotova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суплотова Людмила Александровна, доктор медицинских наук, профессор, заведующая курсом эндокринологии кафедры терапии Института непрерывного профессионального развития</p><p>625023, Тюмень, ул. Одесская, д. 54</p></bio><bio xml:lang="en"><p>Lyudmila A. Suplotova, Dr. Sci. (Med.), Professor, Head of the Endocrinology course of the Department of Therapy of the Institute of Continuous Professional Development</p><p>54, Odesskaya St., Tyumen, 625023</p></bio><email xlink:type="simple">suplotovala@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тюменский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tyumen State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>19</day><month>06</month><year>2022</year></pub-date><volume>0</volume><issue>10</issue><fpage>110</fpage><lpage>114</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шайтарова А.В., Суплотова Л.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Шайтарова А.В., Суплотова Л.А.</copyright-holder><copyright-holder xml:lang="en">Shaitarova A.V., Suplotova L.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/6937">https://www.med-sovet.pro/jour/article/view/6937</self-uri><abstract><p>Синтетические глюкокортикостероиды широко применяются в рутинной медицинской практике в случаях угрозы преждевременных родов и при подозрении на врожденную гиперплазию надпочечников. Доказано снижение показателей смертности недоношенных новорожденных под влиянием данной терапии, а также уменьшение вирилизации наружных гениталий и мозга у плодов женского пола с ВДКН. Врожденная дисфункция коры надпочечников, обусловленная дефицитом 21-гидроксилазы, является распространенным, потенциально летальным заболеванием. Частота заболевания, рассчитанная по данным скрининга новорожденных, составляет 1 случай на 14 000 живых новорожденных среди населения мира, 1 – на 9 638 в России. Дексаметазон проникает через плацентарный барьер, что снижает продукцию АКТГ плода и подавляет фетальную продукцию андрогенов. В то же время предродовое лечение не исключает потребности в пожизненном лечении в будущем и не является профилактикой синдрома потери соли в послеродовом периоде, а безопасность дексаметазона в отношении когнитивного развития детей, пренатально получавших дексаметазон, все еще остается предметом дискуссий. Беспокойство усугубляет тот факт, что дозы дексаметазона, воздействию которых подвергается плод, в 60 раз превышают нормальный уровень кортизола плода. Глюкокортикоидные и минералокортикоидные рецепторы высоко экспрессированы в гиппокампе, миндалевидном теле и префронтальной коре. Эти области, важные для исполнительной деятельности, эмоциональной регуляции, памяти, уязвимы для высоких доз глюкокортикостероидов. Результаты исследований демонстрируют, что антенатальное применение синтетических глюкокортикостероидов ассоциировано с повышенным риском развития метаболических и сердечно-сосудистых нарушений, изменением поведения и когнитивных способностей.</p></abstract><trans-abstract xml:lang="en"><p>Synthetic glucocorticoids are widely used in pregnancies at risk of preterm delivery and in pregnant women at risk of having a child with severe 21-hydroxylase deficiency. The positive effects of reducing mortality in preterm and virilisation in girls with congenital adrenal hyperplasia are now unquestionable. The adrenogenital syndrome responding to 21-hydroxylase deficiency is a common, potential fatal disease. Its incidence calculated on the basis of neonatal screening data makes 1 case for 14000 live newborns among the worldwide population, 1 for 9638 – In Russia. DEX passes through the placenta and decreases fetal ACTH production thereby suppressing the fetal production of androgens. The prenatal treatment does not preclude from a life-long treatment in future and it is not prevention of a salt-losing syndrome at the postnatal period, and dexamethasone safety in relation to cognitive development of children prenatally treated with dexamethasone is still up for debate. Adding to the concern is the fact that the doses of DEX that the fetus is exposed to are estimated to be 60 times the normal fetal cortisol level. The glucocorticoid and the mineralocorticoid receptors are highly expressed in the hippocampus, amygdala, and prefrontal cortex. These areas, important for executive functioning, emotional regulation, and memory, are vulnerable to high doses of GCs. Most experimental data from animal have shown that prenatal exposure to synthetic glucocorticoids programs the foetal HPA and may lead to altered susceptibility to metabolic and cardiovascular disease i.e. metabolic syndrome, high blood pressure. Prenatal glucocorticoid exposure also leads to modification of HPAassociated behaviours and cognition.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глюкокортикоиды</kwd><kwd>беременность</kwd><kwd>отдаленные последствия</kwd><kwd>поведение</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glucocorticoids</kwd><kwd>pregnancy</kwd><kwd>long-term outcome</kwd><kwd>behavior</kwd><kwd>children</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">McGoldrick E., Stewart F., Parker R., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12(12):CD004454. https://doi.org/10.1002/14651858.CD004454.pub4.</mixed-citation><mixed-citation xml:lang="en">McGoldrick E., Stewart F., Parker R., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12(12):CD004454. https://doi.org/10.1002/14651858.CD004454.pub4.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Simhan H.M. Practice Bulletin No. 171: Management of Preterm Labor. Obstet Gynecol. 2016;128(4):155–164. https://doi.org/10.1097/AOG.0000000000001711.</mixed-citation><mixed-citation xml:lang="en">Simhan H.M. Practice Bulletin No. 171: Management of Preterm Labor. Obstet Gynecol. 2016;128(4):155–164. https://doi.org/10.1097/AOG.0000000000001711.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Murphy K.E., Hannah M.E., Willan A.R., Hewson S.A., Ohlsson A., Kelly E.N. et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomized controlled trial. Lancet. 2008;372(9656):2143–2151. https://doi.org/10.1016/S0140-6736(08)61929-7.</mixed-citation><mixed-citation xml:lang="en">Murphy K.E., Hannah M.E., Willan A.R., Hewson S.A., Ohlsson A., Kelly E.N. et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomized controlled trial. Lancet. 2008;372(9656):2143–2151. https://doi.org/10.1016/S0140-6736(08)61929-7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Speiser P.W., Arlt W., Auchus R.J., Baskin L.S., Conway G.S., Merke D.P. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043–4088. https://doi.org/10.1210/jc.2018-01865.</mixed-citation><mixed-citation xml:lang="en">Speiser P.W., Arlt W., Auchus R.J., Baskin L.S., Conway G.S., Merke D.P. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043–4088. https://doi.org/10.1210/jc.2018-01865.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Суплотова Л.А., Храмова Е.Б., Макарова О.Б., Старкова О.Б., Кукарская И.И., Брынза Н.С., Фомина С.В. Скрининг беременных женщин на врожденную дисфункцию коры надпочечников: результаты и перспективы. Проблемы эндокринологии. 2005;(6):12–14. Режим доступа: https://www.probl-endojournals.ru/jour/article/view/10822.</mixed-citation><mixed-citation xml:lang="en">Suplotova L.A., Khramova Е.B., Makarova O.B., Kukarskaya I.I., Brynza N.S., Starkova O.B., Fomina S.V. Screening for congenital adrenal hyperplasia in pregnancy results and perspectives. Problemy Endokrinologii.2005;(6):12–14. (In Russ.) Available at: https://www.probl-endojournals.ru/jour/article/view/10822.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Суплотова Л.А., Храмова Е.Б., Кукарская И.И., Брынза Н.С., Старкова О.Б., Макарова О.Б., Фомина С.В. Использование дексаметазона в терапии угрозы невынашивания беременности у женщин с неклассическими формами врожденной дисфункции коры надпочечников. Медицинская наука и образование Урала. 2004;(4):93.</mixed-citation><mixed-citation xml:lang="en">Suplotova L.A., Khramova Е.B., Makarova O.B., Kukarskaya I.I., Brynza N.S., Starkova O.B., Fomina S.V. Dexamethasone treatment of women with non-classical forms of congenital adrenal dysfunction. Meditsinskaya Nauka i Obrazovanie Urala. 2004;(4):93. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Colciago A., Casati L., Negri-Cesi P., Celotti F. Learning and memory: Steroids and epigenetics. J Steroid Biochem Mol Biol. 2015;150:64–85. https://doi.org/10.1016/j.jsbmb.2015.02.008.</mixed-citation><mixed-citation xml:lang="en">Colciago A., Casati L., Negri-Cesi P., Celotti F. Learning and memory: Steroids and epigenetics. J Steroid Biochem Mol Biol. 2015;150:64–85. https://doi.org/10.1016/j.jsbmb.2015.02.008.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Matsusue Y., Horii-Hayashi N., Kirita T., Nishi M. Distribution of corticosteroid reseptor in mature oligodendrocytes and oligodendrocyte progenitors of the adult mouse brain. J Histochem Cytochem. 2014;62(3):211–226. https://doi.org/10.1369/0022155413517700.</mixed-citation><mixed-citation xml:lang="en">Matsusue Y., Horii-Hayashi N., Kirita T., Nishi M. Distribution of corticosteroid reseptor in mature oligodendrocytes and oligodendrocyte progenitors of the adult mouse brain. J Histochem Cytochem. 2014;62(3):211–226. https://doi.org/10.1369/0022155413517700.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463–475. https://doi.org/10.1038/nrn1683.</mixed-citation><mixed-citation xml:lang="en">de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463–475. https://doi.org/10.1038/nrn1683.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">LeDoux J.E. Evotion Circuits In the Brain. Annu Rev Neurosci. 2000;23:155–184. https://doi.org/10.1146/annurev.neuro.23.1.155.</mixed-citation><mixed-citation xml:lang="en">LeDoux J.E. Evotion Circuits In the Brain. Annu Rev Neurosci. 2000;23:155–184. https://doi.org/10.1146/annurev.neuro.23.1.155.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Funahashi S. Neuronal mechanisms of executive control by the prefrontal cortex. Neurosci Res. 2001;(39):147–165. https://doi.org/10.1016/s0168-0102(00)00224-8.</mixed-citation><mixed-citation xml:lang="en">Funahashi S. Neuronal mechanisms of executive control by the prefrontal cortex. Neurosci Res. 2001;(39):147–165. https://doi.org/10.1016/s0168-0102(00)00224-8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Opitz B. Memory Function and the Hippocampus. Front Neurol Neurosci. 2014;(34):51–59. https://doi.org/10.1159/000356422.</mixed-citation><mixed-citation xml:lang="en">Opitz B. Memory Function and the Hippocampus. Front Neurol Neurosci. 2014;(34):51–59. https://doi.org/10.1159/000356422.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vehaskari V.M., Woods L.L. Prenatal programming of hypertension: lessons from experimental models. J Am Soc Nephrol. 2005;16(9):2545–2556. https://doi.org/10.1681/Asn.2005030300.</mixed-citation><mixed-citation xml:lang="en">Vehaskari V.M., Woods L.L. Prenatal programming of hypertension: lessons from experimental models. J Am Soc Nephrol. 2005;16(9):2545–2556. https://doi.org/10.1681/Asn.2005030300.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hoppe C.C., Evans R.G., Moritz K.M., Cullen-McEwen L.A., Fitzgerald S.M., Dowling J., Bertram J.F. Combined prenatal and postnatal protein restriction influences adult kidney structure, function, and arterial pressure. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R462–R469. https://doi.org/10.1152/ajpregu.00079.2006.</mixed-citation><mixed-citation xml:lang="en">Hoppe C.C., Evans R.G., Moritz K.M., Cullen-McEwen L.A., Fitzgerald S.M., Dowling J., Bertram J.F. Combined prenatal and postnatal protein restriction influences adult kidney structure, function, and arterial pressure. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R462–R469. https://doi.org/10.1152/ajpregu.00079.2006.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Seckl J.R., Holmes M.C. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal “programming” of adult pathophysiology. Nat Clin Pract Endocrinol Metab. 2007;3(6): 479–488. https://doi.org/10.1038/ncpendmet0515.</mixed-citation><mixed-citation xml:lang="en">Seckl J.R., Holmes M.C. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal “programming” of adult pathophysiology. Nat Clin Pract Endocrinol Metab. 2007;3(6): 479–488. https://doi.org/10.1038/ncpendmet0515.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Goyal R., Goyal D., Leitzke A., Gheorghe C.P., Longo L.D. Brain reninangiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci. 2010;17(3):227–238. https://doi.org/10.1177/1933719109351935.</mixed-citation><mixed-citation xml:lang="en">Goyal R., Goyal D., Leitzke A., Gheorghe C.P., Longo L.D. Brain reninangiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci. 2010;17(3):227–238. https://doi.org/10.1177/1933719109351935.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pladys P., Sennlaub F., Brault S., Checchin D., Lahaie I., Lê N.L. et al. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero. Am J Physiol Regul Integr Comp Physiol. 2005;289(6):R1580–1588. https://doi.org/10.1152/ajpregu.00031.2005.</mixed-citation><mixed-citation xml:lang="en">Pladys P., Sennlaub F., Brault S., Checchin D., Lahaie I., Lê N.L. et al. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero. Am J Physiol Regul Integr Comp Physiol. 2005;289(6):R1580–1588. https://doi.org/10.1152/ajpregu.00031.2005.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Boyne M.S., Woollard A., Phillips D.I., Taylor-Bryan C., Bennett F.I., Osmond C. et al. The association of hypothalamic-pituitary-adrenal axis activity and blood pressure in an Afro-Caribbean population. Psychoneuroendocrinology. 2009;34(5):736–742. https://doi.org/10.1016/j.psyneuen.2008.12.005.</mixed-citation><mixed-citation xml:lang="en">Boyne M.S., Woollard A., Phillips D.I., Taylor-Bryan C., Bennett F.I., Osmond C. et al. The association of hypothalamic-pituitary-adrenal axis activity and blood pressure in an Afro-Caribbean population. Psychoneuroendocrinology. 2009;34(5):736–742. https://doi.org/10.1016/j.psyneuen.2008.12.005.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Young J.B. Programming of Sympathoadrenal function. Trends Endocrinol Metab. 2002;13(9):381–385. https://doi.org/10.1016/s1043-2760(02)00661-6.</mixed-citation><mixed-citation xml:lang="en">Young J.B. Programming of Sympathoadrenal function. Trends Endocrinol Metab. 2002;13(9):381–385. https://doi.org/10.1016/s1043-2760(02)00661-6.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Johansson S., Norman M., Legnevall L., Dalmaz Y., Lagercrantz H., Vanpée M. Increased catecholamines and heart rate in children with low birth weight: perinatal contributions to sympathoadrenal overactivity. J Intern Med. 2007;261(5):480–487. https://doi.org/10.1111/j.1365-2796.2007.01776.x.</mixed-citation><mixed-citation xml:lang="en">Johansson S., Norman M., Legnevall L., Dalmaz Y., Lagercrantz H., Vanpée M. Increased catecholamines and heart rate in children with low birth weight: perinatal contributions to sympathoadrenal overactivity. J Intern Med. 2007;261(5):480–487. https://doi.org/10.1111/j.1365-2796.2007.01776.x.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Peltsch H., Khurana S., Byrne C.J., Nguyen P., Khaper N., Kumar A., Tai T.C. Cardiac phenylethanolamine N-methyltransferase: localization and regulation of gene expression in the spontaneously hypertensive rat. Can J Physiol Pharmacol. 2016;94(4):363–372. https://doi.org/10.1139/cjpp-2015-0303.</mixed-citation><mixed-citation xml:lang="en">Peltsch H., Khurana S., Byrne C.J., Nguyen P., Khaper N., Kumar A., Tai T.C. Cardiac phenylethanolamine N-methyltransferase: localization and regulation of gene expression in the spontaneously hypertensive rat. Can J Physiol Pharmacol. 2016;94(4):363–372. https://doi.org/10.1139/cjpp-2015-0303.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen P., Khurana S., Peltsch H., Grandbois J., Eibl J., Crispo J. et al. Prenatal glucocorticoid exposure programs adrenal PNMT expression and adult hypertension. J Endocrinol. 2015;227(2):117–127. https://doi.org/10.1530/JOE-15-0244.</mixed-citation><mixed-citation xml:lang="en">Nguyen P., Khurana S., Peltsch H., Grandbois J., Eibl J., Crispo J. et al. Prenatal glucocorticoid exposure programs adrenal PNMT expression and adult hypertension. J Endocrinol. 2015;227(2):117–127. https://doi.org/10.1530/JOE-15-0244.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wong D.L., Siddall B., Wang W. Hormonal control of rat adrenal phenylethanolamine N-methyltransferase. Enzyme activity, the final critical pathway. Neuropsychopharmacology. 1995;13(3):223–234. https://doi.org/10.1016/0893-133X(95)00066-M.</mixed-citation><mixed-citation xml:lang="en">Wong D.L., Siddall B., Wang W. Hormonal control of rat adrenal phenylethanolamine N-methyltransferase. Enzyme activity, the final critical pathway. Neuropsychopharmacology. 1995;13(3):223–234. https://doi.org/10.1016/0893-133X(95)00066-M.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wong D.L., Anderson L.J., Tai T.C. Cholinergic and peptidergic regulation of phenylethanolamine N-methyltransferase gene expression. Ann N Y Acad Sci. 2002;971:19–26. https://doi.org/10.1111/j.1749-6632.2002.tb04428.x.</mixed-citation><mixed-citation xml:lang="en">Wong D.L., Anderson L.J., Tai T.C. Cholinergic and peptidergic regulation of phenylethanolamine N-methyltransferase gene expression. Ann N Y Acad Sci. 2002;971:19–26. https://doi.org/10.1111/j.1749-6632.2002.tb04428.x.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Tai T.C., Claycomb R., Siddall B.J., Bell R.A., Kvetnansky R., Wong D.L. Stress-induced changes in epinephrine expression in the adrenal medulla in vivo. J Neurochem. 2007;101(4):1108–1118. https://doi.org/10.1111/j.1471-4159.2007.04484.x.</mixed-citation><mixed-citation xml:lang="en">Tai T.C., Claycomb R., Siddall B.J., Bell R.A., Kvetnansky R., Wong D.L. Stress-induced changes in epinephrine expression in the adrenal medulla in vivo. J Neurochem. 2007;101(4):1108–1118. https://doi.org/10.1111/j.1471-4159.2007.04484.x.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Tai T.C., Claycomb R., Her S., Bloom A.K., Wong D.L. Glucocorticoid responsiveness of the rat phenylethanolamine N-methyltransferase gene. Mol Pharmacol. 2002;61(6):1385–1392. https://doi.org/10.1124/mol.61.6.1385.</mixed-citation><mixed-citation xml:lang="en">Tai T.C., Claycomb R., Her S., Bloom A.K., Wong D.L. Glucocorticoid responsiveness of the rat phenylethanolamine N-methyltransferase gene. Mol Pharmacol. 2002;61(6):1385–1392. https://doi.org/10.1124/mol.61.6.1385.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Moisiadis V.G., Matthews S.G. Glucocorticoids and fetal programming part 1: Outcomes. Nat Rev Endocrinol. 2014;10(7):391–402. https://doi.org/10.1038/nrendo.2014.73.</mixed-citation><mixed-citation xml:lang="en">Moisiadis V.G., Matthews S.G. Glucocorticoids and fetal programming part 1: Outcomes. Nat Rev Endocrinol. 2014;10(7):391–402. https://doi.org/10.1038/nrendo.2014.73.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Browne W.V., Hindmarsh P.C., Pasterski V., Hughes I.A., Acerini C.L., Spencer D. et al. Working memory performance is reduced in children with congenital adrenal hyperplasia. Horm Behav. 2015;67:83–91. https://doi.org/10.1016/j.yhbeh.2014.11.014.</mixed-citation><mixed-citation xml:lang="en">Browne W.V., Hindmarsh P.C., Pasterski V., Hughes I.A., Acerini C.L., Spencer D. et al. Working memory performance is reduced in children with congenital adrenal hyperplasia. Horm Behav. 2015;67:83–91. https://doi.org/10.1016/j.yhbeh.2014.11.014.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Stuart F.A., Segal T.Y., Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child. 2005;90(5):500–506. https://doi.org/10.1136/adc.2003.041541.</mixed-citation><mixed-citation xml:lang="en">Stuart F.A., Segal T.Y., Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child. 2005;90(5):500–506. https://doi.org/10.1136/adc.2003.041541.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Meyer-Bahlburg H.F., Dolezal C., Haggerty R., Silverman M., New M.I. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol. 2012;167(1):103–110. https://doi.org/10.1530/EJE-11-0789.</mixed-citation><mixed-citation xml:lang="en">Meyer-Bahlburg H.F., Dolezal C., Haggerty R., Silverman M., New M.I. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol. 2012;167(1):103–110. https://doi.org/10.1530/EJE-11-0789.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hirvikoski T., Nordenström A., Lindholm T., Lindblad F., Ritzén E.M., Wedell A., Lajic S. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab. 2007;92(2):542–548. https://doi.org/10.1210/jc.2006-1340.</mixed-citation><mixed-citation xml:lang="en">Hirvikoski T., Nordenström A., Lindholm T., Lindblad F., Ritzén E.M., Wedell A., Lajic S. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab. 2007;92(2):542–548. https://doi.org/10.1210/jc.2006-1340.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Hirvikoski T., Nordenström A., Wedell A., Ritzén M., Lajic S. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: The Swedish experience and standpoint. J Clin Endocrinol Metab. 2012;97(6):1881–1883. https://doi.org/10.1210/jc.2012-1222.</mixed-citation><mixed-citation xml:lang="en">Hirvikoski T., Nordenström A., Wedell A., Ritzén M., Lajic S. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: The Swedish experience and standpoint. J Clin Endocrinol Metab. 2012;97(6):1881–1883. https://doi.org/10.1210/jc.2012-1222.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Colciago A., Casati L., Negri-Cesi P., Celotti F. Learning and memory: Steroids and epigenetics. J Steroid Biochem Mol Biol. 2015;150:64–85. https://doi.org/10.1016/j.jsbmb.2015.02.008.</mixed-citation><mixed-citation xml:lang="en">Colciago A., Casati L., Negri-Cesi P., Celotti F. Learning and memory: Steroids and epigenetics. J Steroid Biochem Mol Biol. 2015;150:64–85. https://doi.org/10.1016/j.jsbmb.2015.02.008.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hamed S.A., Metwalley K.A., Farghaly H.S. Cognitive function in children with classic congenital adrenal hyperplasia. Eur J Pediatr. 2018;177(11):1633–1640. https://doi.org/10.1007/s00431-018-3226-7.</mixed-citation><mixed-citation xml:lang="en">Hamed S.A., Metwalley K.A., Farghaly H.S. Cognitive function in children with classic congenital adrenal hyperplasia. Eur J Pediatr. 2018;177(11):1633–1640. https://doi.org/10.1007/s00431-018-3226-7.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sewell R., Buchanan C.L., Davis S., Christakis D.A., Dempsey A., Furniss A. et al. Behavioral Health Diagnoses in Youth with Differences of Sex Development or Congenital Adrenal Hyperplasia Compared with Controls: A PEDSnet Study. J Pediatr. 2021;239:175–181.e2. https://doi.org/10.1016/j.jpeds.2021.08.066.</mixed-citation><mixed-citation xml:lang="en">Sewell R., Buchanan C.L., Davis S., Christakis D.A., Dempsey A., Furniss A. et al. Behavioral Health Diagnoses in Youth with Differences of Sex Development or Congenital Adrenal Hyperplasia Compared with Controls: A PEDSnet Study. J Pediatr. 2021;239:175–181.e2. https://doi.org/10.1016/j.jpeds.2021.08.066.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Sotiriadis A., Tsiami A., Papatheodorou S., Baschat A.A., Sarafidis K., Makrydimas G. Neurodevelopmental Outcome After a Single Course of Antenatal Steroids in Children Born Preterm: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015;125(6):1385–1396. https://doi.org/10.1097/AOG.0000000000000748.</mixed-citation><mixed-citation xml:lang="en">Sotiriadis A., Tsiami A., Papatheodorou S., Baschat A.A., Sarafidis K., Makrydimas G. Neurodevelopmental Outcome After a Single Course of Antenatal Steroids in Children Born Preterm: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015;125(6):1385–1396. https://doi.org/10.1097/AOG.0000000000000748.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Cheong J.L., Burnett A.C., Lee K.J., Roberts G., Thompson D.K., Wood S.J. et al. Association between postnatal dexamethasone for treatment of bronchopulmonary dysplasia and brain volumes at adolescence in infants born very preterm. J Pediatr. 2014;164(4):737–743.e1. https://doi.org/10.1016/j.jpeds.2013.10.083.</mixed-citation><mixed-citation xml:lang="en">Cheong J.L., Burnett A.C., Lee K.J., Roberts G., Thompson D.K., Wood S.J. et al. Association between postnatal dexamethasone for treatment of bronchopulmonary dysplasia and brain volumes at adolescence in infants born very preterm. J Pediatr. 2014;164(4):737–743.e1. https://doi.org/10.1016/j.jpeds.2013.10.083.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">de Bie H.M., Oostrom K.J., Delemarre-van de Waal H.A. Brain development, intelligence and cognitive outcome in children born small for gestational age. Horm Res Paediatr. 2010;73(1):6–14. https://doi.org/10.1159/000271911.</mixed-citation><mixed-citation xml:lang="en">de Bie H.M., Oostrom K.J., Delemarre-van de Waal H.A. Brain development, intelligence and cognitive outcome in children born small for gestational age. Horm Res Paediatr. 2010;73(1):6–14. https://doi.org/10.1159/000271911.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Davis E.P., Sandman C.A., Buss C., Wing D.A., Head K. Fetal glucocorticoid exposure is associated with preadolescent brain development. Biol Psychiatry. 2013;74(9):647–655. https://doi.org/10.1016/j.biopsych.2013.03.009.</mixed-citation><mixed-citation xml:lang="en">Davis E.P., Sandman C.A., Buss C., Wing D.A., Head K. Fetal glucocorticoid exposure is associated with preadolescent brain development. Biol Psychiatry. 2013;74(9):647–655. https://doi.org/10.1016/j.biopsych.2013.03.009.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Grant K.A., Sandman C.A., Wing D.A., Dmitrieva J., Davis E.P. Prenatal programming of postnatal susceptibility to memory impairments: a developmental double jeopardy. Psychol Sci. 2015;26(7):1054–1062. https://doi.org/10.1177/0956797615580299.</mixed-citation><mixed-citation xml:lang="en">Grant K.A., Sandman C.A., Wing D.A., Dmitrieva J., Davis E.P. Prenatal programming of postnatal susceptibility to memory impairments: a developmental double jeopardy. Psychol Sci. 2015;26(7):1054–1062. https://doi.org/10.1177/0956797615580299.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Шайтарова А.В., Суплотова Л.А., Храмова Е.Б. Особенности физического и нервно-психического развития детей, матери которых в период беременности принимали дексаметазон. Вопросы гинекологии, акушерства и перинатологии. 2013;(2):43–47. Режим доступа: https://www.phdynasty.ru/katalog/zhurnaly/voprosy-ginekologii-akusherstva-i-perinatologii/2013/tom-12-nomer-21935/12546.</mixed-citation><mixed-citation xml:lang="en">Shaitarova A.V., Suplotova L.A., Khramova Ye.B. Specificities of physical and nervous-mental development of children, whose mothers received dexamethasone during pregnancy. Gynecology, Obstetrics and Perinatology. 2013;(2):43–47. (In Russ.) Available at: https://www.phdynasty.ru/katalog/zhurnaly/voprosy-ginekologii-akusherstva-i-perinatologii/2013/tom-12-nomer-21935/12546.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
